PQLC1P1

Across TCGA pan-cancer cohorts, PQLC1P1 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated PQLC1P1 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher PQLC1P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PQLC1P1 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

HNSC, OV, and STAD are the cancer types where PQLC1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	II,III,IV	0.260	0.599	<.001	123	view →
OV	OS	Tertile	IV	0.269	0.765	.002	36	view →
STAD	DFS	Tertile	III,IV	0.692	0.300	.013	15	view →
LUSC	OS	Tertile	All	0.519	0.778	.036	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

PQLC1P1–HNSC (DFS)

Open the HNSC breakdown →